Global Immunoassay Market Strategies and Trends Research Report 2024 with Executive Guides, Customized Forecasting and Analysis 2023-2027 –

Global Immunoassay Market Strategies and Trends Research Report 2024 with Executive Guides, Customized Forecasting and Analysis 2023-2027 –

Global Immunoassay Market Strategies and Trends Research Report 2024 with Executive Guides, Customized Forecasting and Analysis 2023-2027 –

DUBLIN–(BUSINESS WIRE)–The “Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027” report has been added to’s offering.

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes.

Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. The analyst profiles over 60 companies, large and small, working in this area. Learn all about the pitfalls and opportunities in this extensive report.

Make investment decisions and valuations with confidence using the latest data.

Key Topics Covered:

1 Market Guides

1.1 Immunoassay Market – Strategic Situation Analysis

1.2 Guide for Executives, Marketing, Sales and Business Development Staff

1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

2.1 Immunoassay Markets Definition In This Report

2.1.1 Enzyme Based

2.1.2 Immunofluorescence

2.1.3 Chemiluminescence

2.1.4 DNA/NAT

2.1.5 RIA & Other

2.1.6 Reagents/Kits, Analyzers, Software & Services

2.1.7 Infectious Disease

2.1.8 Auto Immune

2.1.9 Endocrinology

2.1.10 Oncology

2.1.11 Cardiology

2.1.12 Other Specialty

2.2 Market Definition

2.2.1 Market Sizes

2.2.2 Currency

2.2.3 Years

2.3 Methodology

2.3.1 Methodology

2.3.2 Sources

2.3.3 Authors

2.4 Perspective: Healthcare and the IVD Industry

2.4.1 Global Healthcare Spending

2.4.2 Spending on Diagnostics

2.4.3 Important Role of Insurance for Diagnostics

3 Industry Overview

3.1 Players in a Dynamic Market

3.1.1 Academic Research Lab

3.1.2 Diagnostic Test Developer

3.1.3 Instrumentation Supplier

3.1.4 Chemical/Reagent Supplier

3.1.5 Pathology Supplier

3.1.6 Independent Clinical Laboratory

3.1.7 Public National/regional Laboratory

3.1.8 Hospital Laboratory

3.1.9 Physicians Office Lab (POLS)

3.1.10 Audit Body

3.1.11 Certification Body

3.2 The Clinical Laboratory Market Segments

3.2.1 Traditional Market Segmentation

3.2.2 Laboratory Focus and Segmentation

3.2.3 Hospital Testing Share

3.2.4 Economies of Scale

3.2.5 Hospital vs. Central Lab

3.2.6 Physician Office Labs

3.2.7 Physicians and POCT

3.3 Immunoassay – Markets and Discussion

3.3.1 Instruments – Genetics changes the picture RIA – A Technology Shows its Age Immunoassay vs. PCR vs. Sequencing – A See Saw Battle The Smart Shrinking Instrument – Serious Implications Research Funding and Capital Expense – Instrument Pooling Multiplex vs. POC – A Tradeoff Analysis

3.3.2 Reagents and Kits – Genetics changes the picture Bigger Test Menus a Boon for Kit Market Physician Office Labs – A New Frontier

3.3.3 Rapid and POCT to Threaten Instrument Markets

3.3.4 OTC and DTC – Huge Market Potential

3.3.5 Economies of Scale. Going Away?

3.3.6 Lower Barriers to Entry for Instruments/Analyzers

3.3.7 Miniaturization and Technology Drive Acquisition

4 Market Trends

4.1 Factors Driving Growth

4.1.1 Diagnostic Factors

4.1.2 Changing Technologies Spur Early Instrument Retirement

4.1.3 Consumer Channels Open Wider

4.1.4 Immunity Technology Comes of Age

4.2 Factors Limiting Growth

4.2.1 Increased Competition Lowers Price

4.2.2 Threat from PCR Based Instruments

4.2.3 Lower Barriers to Entry

4.2.4 Wellness has a downside

4.3 Immunoassay Instrumentation

4.3.1 Instrumentation Tenacity

4.3.2 Declining Cost of Instruments Changes Industry Structure


4.3.4 Immunoassay – CRISPR Diagnostics

5 Immunoassay Recent Developments

5.1 Recent Developments – Importance and How to Use This Section

5.1.1 Importance of These Developments

5.1.2 How to Use This Section

5.2 EDP Biotech, New Day Diagnostics to Merge

5.3 Sorrento Therapeutics Nabs Contract for Dx Platform

5.4 Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer

5.5 Qorvo Eyes Multiplex Immunoassay

5.6 BioMerieux Launches New Products

5.7 Senzo to Commercialize Infectious Disease Lateral Flow Tests

5.8 Nanomix Plans Instrument, Test Launches

5.9 Startup GLX Analytix Prepares for Commercialization

5.10 Nonagen Gets CE Mark for Bladder Cancer Immunoassay

5.11 Qualigen Acquires Majority Stake in NanoSynex

5.12 Saladax Biomedical Using Immunoassay Dx

5.13 Prolight Diagnostics to Acquire Psyros Diagnostics

5.14 Quidel to Acquire Ortho Clinical Diagnostics

5.15 FDA Grants EUA to Xtrava Health

5.16 Alamar Biosciences Develops Immuno-Sandwich Platform

5.17 FDA grants breakthrough device to multiplex immunoassay

5.18 Quidel, Beckman Settle Cardiac Immunoassay Dispute

5.19 BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership

5.20 BioMerieux Gets CE Mark for Three Dengue Immunoassays

5.21 COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing

5.22 Roche Diagnostics Expanding Testing Portfolio in 2021

5.23 PerkinElmer Long-Term Outlook

5.24 Quidel Updates Outlook for C19 Testing

5.25 Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza

5.26 Becton Dickinson and NAT Diagnostics Acquisition

6 Profiles of Key Companies

6.1 Abbott Laboratories

6.2 Abcam

6.3 Abionic

6.4 Accel Diagnostics

6.5 Applied BioCode

6.6 Arlington Scientific

6.7 Arrayit Corporation

6.8 Atomo Diagnostics

6.9 Aureum Diagnostics

6.10 Aurora Biomed

6.11 Autobio Diagnostics

6.12 AVIVA Systems Biology

6.13 Awareness Technology

6.14 Axis-Shield Diagnostics Ltd.

6.15 Beckman Coulter Diagnostics

6.16 Becton, Dickinson and Company

6.17 Biocartis

6.18 Biomatik

6.19 bioMerieux Diagnostics

6.20 Bioneer Corporation

6.21 Bio-Rad Laboratories, Inc.

6.22 BioTek Instruments

6.23 Boditech Med, Inc

6.24 Boster Biological Technology

6.25 Diamedix (Erba Diagnostics)

6.26 Diasorin S.p.A.

6.27 Dynex Technologies

6.28 Enzo Biochem

6.29 Eurofins Scientific

6.30 FUJIFILM Wako Diagnostics

6.31 Fujirebio

6.32 Gold Standard Diagnostics

6.33 Grifols

6.34 Hycor Biomedical

6.35 Immunodiagnostic Systems (IDS)

6.36 Immunodiagnostik AG

6.37 Inova Diagnostics

6.38 JR Biomedical

6.39 Luminex Corp

6.40 Maxim Biomedical

6.41 Mbio Diagnostics

6.42 Meso Scale Discovery

6.43 Millipore Sigma

6.44 Mindray

6.45 Molecular Devices

6.46 MP Biomedical

6.47 Operon

6.48 Ortho Clinical Diagnostics

6.49 Perkin Elmer

6.50 Qiagen

6.51 Quidel

6.52 R&D Systems

6.53 Randox Toxicology

6.54 Roche Molecular Diagnostics

6.55 SD Biosensor

6.56 Siemens Healthineers

6.57 Sysmex

6.58 Tecan

6.59 Thermo Fisher Scientific Inc.

6.60 TOSOH Bioscience

6.61 Veredus Laboratories

6.62 Vircell

6.63 YD Diagnostics

6.64 Zhejiang Orient Gene Biotech

7 The Global Market

7.1 Global Market by Country

7.2 Global Market by Application

7.3 Global Market by Technology

7.4 Global Market by Product

7.5 Global Market by User

8 Global Market by Application

8.1 Endocrinology Applications

8.2 Immune Applications

8.3 Oncology Applications

8.4 Infectious Disease Applications

8.5 Cardiology Applications

8.6 Other Applications

9 Immunoassay by Technology

9.1 Enzyme

9.2 Flourescence

9.3 Chemiluminescence

9.4 Nucleic Acid

9.5 Rapid/POC

10 Immunoassay by Product

10.1 Instrument

10.2 Reagents

10.3 Services

11 Immunoassay by User

11.1 Hospital

11.2 Outpatient Lab

11.3 POC/Other

12 Vision of the Future of Immunoassay

13 Appendices

13.1 United States Medicare System: Laboratory Fees Schedule

13.2 The Most Used IVD Assays

13.3 The Highest Grossing Assays

For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900